Atjaunināt sīkdatņu piekrišanu

Advances in Nuclear Oncology:: Diagnosis and Therapy [Hardback]

Edited by (Royal Free Hospital, London, UK), Edited by (Instituto Europeo Oncologia, University of Milan, Milan Italy), Edited by (Klinik und Poliklinik fur Nuklearmedizin, University Munster, Munster Germany), Edited by
  • Formāts: Hardback, 544 pages, height x width: 280x210 mm, weight: 1170 g, 106 Tables, black and white; 28 Line drawings, color; 72 Line drawings, black and white; 293 Halftones, color; 507 Halftones, black and white; 321 Illustrations, color; 579 Illustrations, black and white
  • Izdošanas datums: 15-Oct-2007
  • Izdevniecība: CRC Press
  • ISBN-10: 1841846147
  • ISBN-13: 9781841846149
Citas grāmatas par šo tēmu:
  • Hardback
  • Cena: 282,30 €
  • Grāmatu piegādes laiks ir 3-4 nedēļas, ja grāmata ir uz vietas izdevniecības noliktavā. Ja izdevējam nepieciešams publicēt jaunu tirāžu, grāmatas piegāde var aizkavēties.
  • Daudzums:
  • Ielikt grozā
  • Piegādes laiks - 4-6 nedēļas
  • Pievienot vēlmju sarakstam
  • Bibliotēkām
  • Formāts: Hardback, 544 pages, height x width: 280x210 mm, weight: 1170 g, 106 Tables, black and white; 28 Line drawings, color; 72 Line drawings, black and white; 293 Halftones, color; 507 Halftones, black and white; 321 Illustrations, color; 579 Illustrations, black and white
  • Izdošanas datums: 15-Oct-2007
  • Izdevniecība: CRC Press
  • ISBN-10: 1841846147
  • ISBN-13: 9781841846149
Citas grāmatas par šo tēmu:
The diagnostic and therapeutic achievements in radiopharmaceuticals and nuclear medicine instrumentation – PET, SPECT, MR, CT and their hypbrids PET-CT and SPECT-CT – are the result of the interdisciplinary research efforts of cell-biologists, chemists, pharmacologists, physicists, computer-scientists, engineers, nuclear medicine physicians, and oncologists. The clinical implications of these achievements have made nuclear medicine indispensable in the management of cancer. This superbly illustrated text on modern nuclear medicine applications in the diagnosis and treatment of cancer describes the state of the art and the current position of nuclear medicine in the light of these recent developments. It is intended as a valuable update also for non-nuclear medicine specialists working in oncology. Nuclear medicine as part of molecular imaging and therapy has changed radically in the last decade. The growing importance and clinical impact of these changes in the near future has impelled the internationally renowned editors and contributors to put them on record in Advances in Nuclear Oncology
List of contributors
vii
Preface xi
Acknowledgments xii
I: Biology of cancer
What is cancer?
1(16)
Uwe Haberkorn
Targets
17(6)
Christoph Bremer
Michael Schafers
II: Diagnostic applications
Primary brain tumors
23(28)
Eva Orunesu
Andreas Jacobs
Andrea Falini
Angelo Del Sole
Giovanni Lucignani
Head and neck cancer
51(10)
Flavio Crippa
Alberto Gerali
Alessandra Alessi
Lung cancer
61(28)
Richard P Baum
Vikas Prasad
Wolfgang A Weber
Esophageal cancer
89(10)
Cristina Nanni
Sara Taddayon
Guido Biasco
Stefano Fanti
Arturo Chiti
Colorectal cancer
99(10)
Ken Herrmann
Bernd Joachim Krause
Prostate cancer
109(24)
Werner Langsteger
Mohsen Beheshti
Reza Vali
Avi Beri
Michael Nader
Guenter Janetschek
Ovarian cancer
133(10)
Sandro Sironi
Maria Picchio
Luca Guerra
Cristina Messa
Ferrauccio Fazio
Breast cancer
143(18)
Emilio Bombardieri
Marco Maccauro
Orazio Schillaci
Flavio Crippa
Thyroid cancer
161(16)
Peter Lind
Susanne Kohlfurst
Adrenal tumors
177(12)
Christiane Franzius
Otmar Schober
Neuroendocrine gastroenteropancreatic tumors
189(14)
Emilia Bombardieri
Angela Coliva
Marco Maccauro
Ettore Seregni
Irene Virgolini
Lymphoma
203(20)
Simona Ben-Haim
Ora Israel
Bone and soft tissue tumors
223(30)
Gopinath Gnanasegaran
Gary Cook
Sanjay Vijayanathan
Ignac Fogelman
Malignant melanoma
253(12)
Ehab M Kamel
Angelika Bischof Delaloye
Cancer of unknown primary
265(10)
Emilio Bombardieri
Stefano Fanti
Arturo Chiti
Cristina Nanni
Angela Coliva
Enrico Pelosi
Gianni Bisi
III: Therapeutic applications
Therapy of differentiated thyroid cancer
275(18)
Martin Biermann
Otmar Schober
Therapy of medullary thyroid cancer
293(6)
Aurore Oudoux
Catherine Ansquer
Jacques Barbet
David M Goldenberg
Jean-Francois Chatal
Francoise Kraeber-Bodere
Therapy of lymphoma
299(16)
Tim Illidge
Yong Du
Therapy of neuroendocrine tumors
315(26)
Irene Virgolini
Ulrich Andergassen
Tatjana Traub-Weidinger
Dirk Heute
Elisabeth von Guggenberg
Dorota Kendler
Margarida Rodrigues
Georg Dobrozemsky
Boris Warwitz
Daniel Putzer
Roy Moncayo
Clemens Decristoforo
Michael Gabriel
Therapy of bone metastases
341(10)
Holger Palmedo
Therapy of liver tumors
351(8)
John Buscombe
Therapy of colorectal cancer
359(8)
John Buscombe
Therapy of brain tumors
367(16)
Chiara Maria Grana
Mirco Bartolomei
Mahila Ferrari
Giovanni Paganelli
Therapy of ovarian cancer
383(14)
Angela Coliva
Ettore Seregni
Mariangela Figini
Alberto Zacchetti
Rosanna Fontanelli
Francesco Raspagliesi
Silvana Canevari
Emilio Bombardieri
IV: Methods and technology
New instrumentation
397(16)
Jorg Eckardt
Klaus Schafers
Lars Stegger
New radiopharmaceuticals for cancer diagnosis
413(20)
Jane K Sosabowski
Matthias Glaser
Stephen J Mather
Radiopharmaceuticals for therapy
433(10)
Margaret S Cooper
John Buscombe
New concepts in dosimetry and radiation protection
443(24)
Michael Lassmann
Manuel Bardies
Carlo Chiesa
Wolfgang Escchner
Glenn Flux
Myriam Monsicurs
Sauli Savolainen
Sven-Erik Strand
Advances in nuclear medicine imaging in oncology
467(32)
Carlo Chiesa
Roberta Matheoud
Marco Brambilla
Gian Luca Poli
Nuclear medicine-guided radiotherapy
499(22)
Diana Salvo
Annibale Versari
Cinzia Iotti
Marta Paiusco
Index 521


Bombardieri, Emilio; Buscombe, John; Lucignani, Giovanni; Schober, Otmar